Tong D - Search Results

1

The roles of the COX2/PGE2/EP axis in therapeutic resistance.

Tong D, Liu Q, Wang LA, Xie Q, Pang J, Huang Y, Wang L, Liu G, Zhang D, Lan W, Jiang J. Tong D, et al. Cancer Metastasis Rev. 2018 Sep;37(2-3):355-368. doi: 10.1007/s10555-018-9752-y. Cancer Metastasis Rev. 2018. PMID: 30094570 Review.

2

Complex behaviours--new targets against cancer.

Tong D, Jiang J. Tong D, et al. Nat Rev Clin Oncol. 2013 Feb;10(2). doi: 10.1038/nrclinonc.2012.127-c2. Epub 2012 Dec 18. Nat Rev Clin Oncol. 2013. PMID: 23247376 No abstract available.

3

Publications from China in The Lancet, NEJM, and JAMA.

Tong D, Wang L, Jiang J. Tong D, et al. Lancet. 2013 Jun 8;381(9882):1983. doi: 10.1016/S0140-6736(13)61197-6. Lancet. 2013. PMID: 23746894 No abstract available.

4

Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.

Wang Y, Liu G, Tong D, Parmar H, Hasenmayer D, Yuan W, Zhang D, Jiang J. Wang Y, et al. Among authors: tong d. Prostate. 2015 Aug 1;75(11):1187-96. doi: 10.1002/pros.23000. Epub 2015 Apr 20. Prostate. 2015. PMID: 25894097

5

Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis.

Liu Q, Yuan W, Tong D, Liu G, Lan W, Zhang D, Xiao H, Zhang Y, Huang Z, Yang J, Zhang J, Jiang J. Liu Q, et al. Among authors: tong d. Oncotarget. 2016 May 10;7(19):28235-46. doi: 10.18632/oncotarget.8595. Oncotarget. 2016. PMID: 27058422 Free PMC article.

6

Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis.

Tong D, Liu Q, Liu G, Xu J, Lan W, Jiang Y, Xiao H, Zhang D, Jiang J. Tong D, et al. Cancer Lett. 2017 Mar 28;389:23-32. doi: 10.1016/j.canlet.2016.12.031. Epub 2016 Dec 30. Cancer Lett. 2017. PMID: 28043910

7

Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families.

Liu Q, Tong D, Yuan W, Liu G, Yuan G, Lan W, Zhang D, Zhang J, Huang Z, Zhang Y, Jiang J. Liu Q, et al. Among authors: tong d. Medicine (Baltimore). 2017 Jan;96(3):e5967. doi: 10.1097/MD.0000000000005967. Medicine (Baltimore). 2017. PMID: 28099363 Free PMC article.

8

A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review.

Liu Q, Wang Y, Tong D, Liu G, Yuan W, Zhang J, Ye J, Zhang Y, Yuan G, Feng Q, Zhang D, Jiang J. Liu Q, et al. Among authors: tong d. Endocr Pathol. 2017 Mar;28(1):75-82. doi: 10.1007/s12022-017-9469-4. Endocr Pathol. 2017. PMID: 28116635 Review.

9

Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT.

Liu Q, Tong D, Liu G, Xu J, Do K, Geary K, Zhang D, Zhang J, Zhang Y, Li Y, Bi G, Lan W, Jiang J. Liu Q, et al. Among authors: tong d. Cell Death Dis. 2017 Aug 24;8(8):e3007. doi: 10.1038/cddis.2017.417. Cell Death Dis. 2017. PMID: 28837141 Free PMC article.

10

Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells.

Wilson S, Cavero L, Tong D, Liu Q, Geary K, Talamonti N, Xu J, Fu J, Jiang J, Zhang D. Wilson S, et al. Among authors: tong d. Oncotarget. 2017 May 19;8(33):54683-54693. doi: 10.18632/oncotarget.18003. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903374 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,394 results

Search Page

Filters